FUNDING ALERT: ARPA-H
Submit Abstracts Early, Reviewed on Rolling Basis!
All High Risk, High Reward ideas welcome!
REGISTER TO SUBMIT YOUR ABSTRACT: https://ecps.nih.gov/ (Enter keywords in left panel: ARPA-H BAA)
YOUR 3-PAGE ABSTRACT: Proposers are encouraged to use the Heilmeier Catechism questions to prepare their abstract. Each compliant abstract will receive a response within 4-6 weeks of submission, possibly requesting a full proposal.
ABSTRACT REQUIREMENTS (3 pages max): (1) Cover page (2) Concept Summary (3) Innovation & Impact (4) Proposed Work (5) Organization and Capabilities (6) Cost estimate. See page 11 of the funding opportunity for abstract format guidelines/page limits.
REVIEW PROCESS: Submit your abstracts early! They are reviewed on a rolling basis until March 24, 2024 and funding is limited.
PRESENTATIONS/Q&A OFFERED BY CU ANSCHUTZ VICE CHANCELLOR'S OFFICE OF RESEARCH DEVELOPMENT AND STRATEGY: Your group can learn more about the new ARPA-H Funding Opportunity! Request form here.
QUESTIONS: Please contact Diane.Ladell@cuanschutz.edu.
06/15/23 — NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)
7/14/23 — NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
09/10/24 — NIH Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
09/12/23 — NIH Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
09/22/23 — NIH BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
High Quality Reference Genomes (HQRG) (UM1 Clinical Trial Not Allowed)
The Division of Endocrinology, Metabolism and Diabetes in the Department of Medicine at the University of Colorado Anschutz Medical Campus is now accepting applications to provide salary support for post-doctoral research training in metabolism, obesity and type 2 diabetes.
During the period of support trainees will have the opportunity to work in montor-based research using model systems that extend from genetic studies in flies, mechanistic studies in animals and humans to interventional studies in people with diabetes or obesity and epidemiologial studies in populations across the lifespan.
Trainees will have the opportunity to take part in a range of seminars, workshops and specialized training opportunities.
Contact Dan Bessesen, MD, if you have any questions.
The Award recognizes a single paper of empirical biomedical research of outstanding scientific quality published in a peer-reviewed journal since 2014.
Nominations may be submitted by an organized group of scientists, such as a university, society, academy, or research institute. The nominating group should not include individuals who contributed to the nominated work.
Nominations are welcomed for works authored by scientists at any stage of their career, and from any country around the world.
Visit the BIAL Foundation website for further information.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.